Skip to main content
Clinical Trials/NCT01808430
NCT01808430CompletedNot Applicable

Real World Outcomes of Video-Assisted Thoracoscopic Surgery for Lung Cancer Using ECHELON FLEX™ Powered ENDOPATH® Stapler: a Prospective European Multicenter Study

Ethicon Endo-Surgery (Europe) GmbH1 site in 1 country158 target enrollmentStarted: March 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
158
Locations
1
Primary Endpoint
occurrence and duration of post-operative air leak

Study Overview

Brief Summary

This study aims to collect real world outcomes of Video-Assisted Thoracoscopic Surgery (VATS) for lung cancer (lobectomy, wedge resection) using ECHELON FLEX™ Powered ENDOPATH® Staplers 45 mm and/or 60 mm (study devices).

Detailed Description

The European prospective observational multi-center cohort study aims to collect real-world outcomes of consecutive patients scheduled for VATS lobectomy for histologically confirmed Non-Small Cell Lung Cancer (NSCLC) or scheduled for VATS wedge resection for undiagnosed pulmonary nodule or metastasis from colorectal cancer (CRC) in accordance with their institution's Standard-of-care (SOC).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Histologically confirmed NSCLC (up to and including Stage II) for patients undergoing VATS lobectomy. For patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from CRC, a malignant diagnosis may be confirmed post-operatively.
  • Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
  • Willing to give consent and comply with evaluation and treatment schedule
  • At least 18 years of age

Exclusion Criteria

  • Active bacterial infection or fungal infection
  • Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
  • Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
  • Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed);
  • Prior history of VATS or open lung surgery

Outcomes

Primary Outcomes

occurrence and duration of post-operative air leak

Time Frame: prolonged air leak defined as longer than 5 days post-op

occurrence and duration of prolonged air leak defined as longer than 5 days

Secondary Outcomes

  • volume of estimated intra-operative blood loss(blood loss intra-op and up to 5 days post-op)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials